Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma

article OA: closed CC0 ⤵ 68 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-10

Loss of ARID1A expression occurs early in tumor progression, distinguishing ovarian endometriotic cysts from subsequent clear cell and endometrioid carcinomas.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma, Clear Cell Biomarkers, Tumor Carcinoma, Endometrioid Cysts Endometriosis Nuclear Proteins Ovarian Neoplasms Transcription Factors Adenocarcinoma, Clear Cell Adenocarcinoma, Clear Cell Adult Aged Biomarkers, Tumor Carcinoma, Endometrioid Carcinoma, Endometrioid Cysts Cysts DNA-Binding Proteins Endometriosis Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:04.919516+00:00
License: CC0 · commercial use OK